SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLTR COULTER PHARMACEUTICAL
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (425)12/4/1999 7:43:00 PM
From: Bob L   of 666
 
As you say, the BLA is what it is all about now. But it is fun to see stuff like this, which I found on ABCnews.com Friday market wrapup:

Coulter Pharmaceuticals leapt 3 3/8, or 22.1 percent, to a post-offering high of 18 7/8 on advance word of promising data on the company's Bexxar non-Hodgkins lymphoma treatment. BT Alex. Brown reiterated a strong buy rating.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News